Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Ketorolac Buccal Infiltration on Success Rate of Inferior Alveolar Nerve Block in Patients With Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial

NCT02536430 is registered in ClinicalTrials.gov with Nahid Mohammadzadeh Akhlaghi as lead sponsor.

NCT NCT02536430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02536430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Ketorolac Buccal Infiltration on Success Rate of Inferior Alveolar Nerve Block in Patients With Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial
Lead sponsor
Nahid Mohammadzadeh Akhlaghi
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2015
Completion date
August 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

failed mechanical induction